Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung CancerN. Engl. J. Med 2020 Sep 03;383(10)944-957, J Wolf, T Seto, JY Han, N Reguart, EB Garon, HJM Groen, DSW Tan, T Hida, M de Jonge, SV Orlov, EF Smit, PJ Souquet, J Vansteenkiste, M Hochmair, E Felip, M Nishio, M Thomas, K Ohashi, R Toyozawa, TR Overbeck, F de Marinis, TM Kim, E Laack, A Robeva, S Le Mouhaer, M Waldron-Lynch, B Sankaran, OA Balbin, X Cui, M Giovannini, M Akimov, RS Heist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.